Advisory Committees
-
Slides for the September 16, 2010 Meeting of the Psychopharmacologic Drugs Advisory Committee
Persons with disabilities having problems accessing the PDF file(s) below may call (301) 796-3634 for assistance
FDA
Rachel Skeete, M.D., DAAP, ODE II, OND, CDER, FDA
Srikanth C. Nallani, Ph.D., Office of Clinical Pharmacology, OTS, CDER, FDA
Feng Li, Ph.D., Division of Biometrics II, Office of Biostatistics, OTS, CDER, FDA
Sponsor
-
-







